These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32588405)

  • 1. [Agranulocytosis after use of metamizole - an underestimated risk?].
    Schinz K; Waldfahrer F; Wüst W; Iro H
    Laryngorhinootologie; 2020 Oct; 99(10):707-712. PubMed ID: 32588405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis].
    Send T; Westermann S; Eichhorn KW; Jakob M
    HNO; 2015 Mar; 63(3):215-9. PubMed ID: 25515122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
    Stammschulte T; Ludwig WD; Mühlbauer B; Bronder E; Gundert-Remy U
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1129-38. PubMed ID: 26169297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric Agranulocytosis Associated with Metamizole Treatment.
    Kılıç Ö; İşeri Nepesov M; Ulukapı HB; Özdemir ZC; Bör Ö; Dinleyici EÇ
    Paediatr Drugs; 2021 Jan; 23(1):105-110. PubMed ID: 33247375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy].
    Skaistys A; Rätz Bravo AE; Leuppi-Taegtmeyer A; Zysset Y
    Praxis (Bern 1994); 2019 Aug; 108(10):693-697. PubMed ID: 31387493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who gets dipyrone (metamizole) in Germany? Prescribing by age, sex and region.
    Hoffmann F; Meinecke P; Freitag MH; Glaeske G; Schulze J; Schmiemann G
    J Clin Pharm Ther; 2015 Jun; 40(3):285-8. PubMed ID: 25776531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA; Meißner W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adequacy of the safety of metamizole and agranulocytosis].
    Garcia Del Campo C; Murcia Soler M; Martinez-Mir I; Palop Larrea V
    Aten Primaria; 2021; 53(6):102047. PubMed ID: 33823317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukopenia with unclear fever].
    Mayer S; Kündiger T; Schrader H
    Internist (Berl); 2017 Jul; 58(7):740-744. PubMed ID: 28265684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
    Lutz M
    J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.